Healthcare -
Biotechnology - NASDAQ - US
$ 28.87
0.698 %
$ 3.24 B
Market Cap
-28.58
P/E
VKTX - STOCK-BASED COMPENSATION
Stock-based Compensation VKTX - Viking Therapeutics, Inc.
16.8 M
LAST VALUE
65.71%
2 YEAR CAGR
45.06%
5 YEAR CAGR
364.87%
10 YEAR CAGR